• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.61 Down 0.01(1.61%) 4:00PM EST
    Add to Portfolio
    Prev Close:0.62
    Open:0.62
    Bid:0.61 x 14700
    Ask:0.63 x 2600
    1y Target Est:9.00
    Beta:0.9
    Next Earnings Date:N/A
    Day's Range:0.61 - 0.64
    52wk Range:0.59 - 4.16
    Volume:103,203
    Avg Vol (3m):243,602
    Market Cap:14.02M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCDown 1.61%14.02M
    AZNDown 1.22%89.69B
    JNJDown 0.60%284.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback